On September 24, 2026, Teppei Sakano, Board Director of Cartanova, took the stage to deliver a presentation at the World Cancer Congress 2026 held in Hong Kong.

This session was held under the theme of "Integrating AMR, Digital Transformation and Behavioral Science in Cancer Care."

Joining experts from the World Health Organization (WHO) and other international leaders, Mr. Sakano presented on the topic "FUTURE SOLUTIONS: GENERATIVE AI & AMR DIAGNOSTICS."

In his presentation, he highlighted the critical importance of addressing infection risks and Antimicrobial Resistance (AMR) in cancer care. He introduced cutting-edge technological approaches to building a safer healthcare environment by leveraging DX and Generative AI, drawing on practical implementation cases in Ukraine.

Cartanova remains committed to contributing to AMR countermeasures—a major global public health threat—and enhancing the quality of cancer care through the provision of medical DX and advanced technologies.

Session Overview

• Date: September 24, 2026

• Venue: Hong Kong Convention and Exhibition Centre (HKCEC)

• Session Theme: Integrating AMR, Digital Transformation and Behavioral Science in Cancer Care

• Presentation Title: FUTURE SOLUTIONS: GENERATIVE AI & AMR DIAGNOSTICS

Speakers

• Dr. André Ilbawi (Team Lead for Cancer Control, WHO)

• Dr. Asem H. Mansour (CEO & Director General, King Hussein Cancer Center)

• Prof. Dr. Murallitharan Munisamy (Managing Director, National Cancer Society of Malaysia)

• Teppei Sakano (Board Director, Cartanova / Board Director, Asia Cancer Forum)

• Chair: Dr. Masaru Iwasaki (Board Director, Asia Cancer Forum)

• Organiser: Dr. Norie Kawahara (Representative Director, Asia Cancer Forum)